SEC Form 4 · accession 0001706903-26-000006
MACROGENICS INC · MGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Stuart Peters
Officer — Senior VP, GC, and Secretary
Period of report
Aug 19, 2026
Accepted (ET)
Aug 20, 2026 · 6:19 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001125345
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 19, 2026 | S | 31,105 | $4.15 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2026.
- F2This transaction was executed in multiple trades at prices ranging from $4.12 to $4.24. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.